Body weight adapted tinzaparin treatment in patients with obesity

Thromb Res. 2022 Jun:214:65-67. doi: 10.1016/j.thromres.2022.04.011. Epub 2022 Apr 20.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticoagulants* / adverse effects
  • Body Weight
  • Fibrinolytic Agents / therapeutic use
  • Heparin, Low-Molecular-Weight* / therapeutic use
  • Humans
  • Obesity / complications
  • Obesity / drug therapy
  • Tinzaparin / therapeutic use

Substances

  • Anticoagulants
  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Tinzaparin